MEGAPARIN 40MG INJECTION contains Enoxaparin which belongs to the group of medicines called Anticoagulants. It is used to treat and prevent blood clot formation in the body.
MEGAPARIN 40MG INJECTION works by stopping the blood clots formation. It also prevents the existing blood clots from growing bigger in size. Due to this property, it is highly used as a prophylactic therapy for preventing blood clot formation during risky conditions that involves clot formation such as before or after a surgery, during dialysis or after a heart attack or a severe chest pain (angina).
It can also be used to reduce the risk of blood clot formation caused due to prolong period of immobility or due to cancer therapy.
Before receiving MEGAPARIN 40MG INJECTION inform your doctor if you have any liver, kidney or heart problems. You must also inform your doctor if you have diabetes, high blood pressure or a history of stomach ulcer.
MEGAPARIN 40MG INJECTION is not recommended for use in patients who are bleeding heavily or have any pre-existing conditions (such as stomach ulcer or stroke) that can increase the risk of internal bleeding. It is also not suitable for use in patients scheduled for spinal anesthesia or lumbar puncture.
Inform your doctor before receiving MEGAPARIN 40MG INJECTION if you are pregnant or breastfeeding. The most common side effects of receiving MEGAPARIN 40MG INJECTION are injection site reactions (such as pain or irritation), skin rashes, low platelet count, bleeding or bruising and headache. Consult your doctor if any of these side effect worsens.
MEGAPARIN 40MG INJECTION is an anticoagulant medicine. It inactivates certain proteins (such as coagulation factor II a and X a) in the blood that causes blood clotting. This reduces the chances of blood clot formation within the body which therefore prevents blockage of blood vessels.
MEGAPARIN 40MG INJECTION will be given to you only by a doctor or a nurse into the vein (intravenously) or under the skin (subcutaneously).
It can also be self-administered by the patients if advised by the physician. Carefully, follow the instructions given by the doctor in case of self-administration.
Your doctor will decide the correct dose and duration of therapy for you depending upon your age, body weight and disease condition.
Contact your doctor immediately if you experience any of the following side effects after receiving MEGAPARIN 40MG INJECTION:
Rest and relax. Keep yourself hydrated by drinking plenty of fluids such as water or electrolytes. Applying a pain-relieving balm on your forehead can be beneficial. Do not consume excessive alcohol, as it could aggravate your headache. Consult your doctor if your headache worsens.
Place an ice pack on the affected area. Do not frequently move the injection site. Consult your doctor if the symptom did not improve.
MEGAPARIN 40MG INJECTION should be used in pregnant women only if it is considered necessary by the physician. Therefore, consult your doctor before receiving it.
MEGAPARIN 40MG INJECTION should be used with caution in breastfeeding women. Therefore, consult your doctor before receiving it.
MEGAPARIN 40MG INJECTION does not affect your ability to drive or operate machinery. However, do not drive or handle any heavy tools or machines if your ability is affected by MEGAPARIN 40MG INJECTION.
Avoid consumption of alcohol before receiving MEGAPARIN 40MG INJECTION.
MEGAPARIN 40MG INJECTION should be used with caution in patients with kidney problems. Therefore, consult your doctor before receiving it.
MEGAPARIN 40MG INJECTION should be used with caution in patients with liver problems. Therefore, consult your doctor before receiving it.
Talk to your doctor before receiving MEGAPARIN 40MG INJECTION if you are allergic to Enoxaparin or to any other low molecular weight heparins (such as nadroparin, tinzaparin or dalteparin).
MEGAPARIN 40MG INJECTION should be used with caution in patients fitted with heart valves and in patients with heart problems (such as heart infections or high blood pressure). Therefore, consult your doctor before receiving it.
The safety and effectiveness of MEGAPARIN 40MG INJECTION have not been established in children and adolescents (aged below 18 years). Your doctor will decide about administering MEGAPARIN 40MG INJECTION to your child after evaluating the risks and benefits of the therapy.
MEGAPARIN 40MG INJECTION should be used with caution in elderly patients (aged 65 years or older). Therefore, consult your doctor before receiving it.
MEGAPARIN 40MG INJECTION is not recommended for use if you:
Before receiving MEGAPARIN 40MG INJECTION, inform your doctor if you:
A. Drug-Drug interactions:
Before receiving MEGAPARIN 40MG INJECTION, inform your doctor if you are taking any of the following medicines:
Overdosage:
MEGAPARIN 40MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms.
Drug | : | Enoxaparin |
Pharmacological Category | : | Parenteral Anticoagulants |
Therapeutic Indication | : | Blood clots |
Dosage Forms | : | Injection, Pre-filled syringes (PFS), Pen, Cartridge |
Q: What is the use of MEGAPARIN 40MG INJECTION?
A: MEGAPARIN 40MG INJECTION is an anticoagulant used to treat and prevent blood clots in the body. It works by stopping the blood clots formation and prevents the existing blood clots from growing bigger in size.
Q: How MEGAPARIN 40MG INJECTION works?
A: MEGAPARIN 40MG INJECTION is an anticoagulant medicine. It inactivates certain proteins (such as coagulation factor II a and X a) in the blood that causes blood clotting. This reduces the chances of blood clot formation within the body which therefore prevents blockage of blood vessels.
Q: How MEGAPARIN 40MG INJECTION is administered?
A: MEGAPARIN 40MG INJECTION will be given to you only by a doctor or a nurse into the vein (intravenously) or under the skin (subcutaneously). It can also be self-administered by the patients if advised by the physician. Carefully, follow the instructions given by the doctor in case of self-administration.
Q: What precautions must be followed while receiving MEGAPARIN 40MG INJECTION?
A: Before receiving MEGAPARIN 40MG INJECTION inform your doctor if you have any liver, kidney or heart problems. You must also inform your doctor if you have diabetes, high blood pressure or a history of stomach ulcer. MEGAPARIN 40MG INJECTION is not recommended for use in patients who are bleeding heavily or have any pre-existing conditions (such as stomach ulcer or stroke) that can increase the risk of internal bleeding. It is also not suitable for use in patients scheduled for spinal anesthesia or lumbar puncture. Inform your doctor before receiving MEGAPARIN 40MG INJECTION if you are pregnant or breastfeeding.
Q: Is MEGAPARIN 40MG INJECTION safe?
A: MEGAPARIN 40MG INJECTION is considered safe at the doses administered by the physician. However, consult your doctor if you experience any unusual side effects.
Q: What are the common side effects of receiving MEGAPARIN 40MG INJECTION?
A: The most common side effects of receiving MEGAPARIN 40MG INJECTION are injection site reactions (such as pain or irritation), skin rashes, low platelet count, bleeding or bruising and headache. Consult your doctor if any of these side effect worsens.
Q: Can the use of MEGAPARIN 40MG INJECTION make me bleed more?
A: As MEGAPARIN 40MG INJECTION is a blood thinning medicine, it makes your blood thin and flowy which might increase the risk of excessive bleeding. To avoid this, your doctor will carefully evaluate your condition and prescribe a suitable dose for you. As a precaution, you must also inform your doctor if you have or recently had any surgery or have any pre-existing conditions (such as stomach ulcer or stroke) that can increase the risk of internal bleeding.
Q: Can MEGAPARIN 40MG INJECTION be used during heart attack?
A: MEGAPARIN 40MG INJECTION can be used to prevent blood clots in patients who suffered a heart attack. However, consult your doctor before taking it.
Q: Who should not receive MEGAPARIN 40MG INJECTION?
A: MEGAPARIN 40MG INJECTION is not recommended for use in patients who are bleeding heavily or have any pre-existing conditions (such as stomach ulcer or stroke) that can increase the risk of internal bleeding. It is also not suitable for use in patients scheduled for spinal anaesthesia or lumbar puncture.
Q: Can I stop receiving MEGAPARIN 40MG INJECTION once my symptoms subside?
A: Do not stop taking MEGAPARIN 40MG INJECTION without consulting your doctor. You need to receive MEGAPARIN 40MG INJECTION for the duration recommended by your doctor to achieve complete prevention of blood clot formation within your body.
Q: Is MEGAPARIN 40MG INJECTION heparin?
A: Yes. MEGAPARIN 40MG INJECTION contains a medicine called enoxaparin which is a low molecular weight heparin.
Q: Can I use MEGAPARIN 40MG INJECTION during pregnancy?
A: MEGAPARIN 40MG INJECTION should be used with caution in pregnant women especially those with a mechanical heart valve. If you are pregnant, think you may be pregnant or are planning to get pregnant, consult your doctor before receiving MEGAPARIN 40MG INJECTION.
Q: Can MEGAPARIN 40MG INJECTION be used in children?
A: The safety and effectiveness of MEGAPARIN 40MG INJECTION have not been established in children and adolescents (aged below 18 years). Your doctor will decide about administering MEGAPARIN 40MG INJECTION to your child after evaluating the risks and benefits of the therapy.
Q: Can MEGAPARIN 40MG INJECTION be given IV?
A: MEGAPARIN 40MG INJECTION will be given to you only by a physician or a nurse under the skin (subcutaneously). It can also be given into your vein (intravenously) during surgeries or after heart attack. Your doctor will decide the appropriate route of administration for you depending upon your medical condition.
Q: Can MEGAPARIN 40MG INJECTION cause thrombocytopenia?
A: MEGAPARIN 40MG INJECTION can lower your blood platelet count (thrombocytopenia), making you bruise more easily than usual. Consult your doctor if you experience any unusual bruising.
1. KD. Tripathi. Drugs affected coagulation, bleeding and thrombosis. Essentials of Medical Pharmacology. 7th Edition. 2013. Page – 619.
2. Takeo Nomura, Mika Takahashi, Kazunori Iwasaki, Tomoya Oribe, Mayuka Shinohara, Yuko Fukuda, Shinsuke Mizoguchi, Fuminori Sato, Hiromitsu Mimata. Efficacy and Safety of Enoxaparin for Preventing Venous Thromboembolic Events following Urologic Laparoscopic Surgery. International Scholarly Research Notices. April 2013. [Accessed on 28th October 2022] https://www.hindawi.com/journals/isrn/2013/415918/
3. Health-Med spólka z ograniczona odpowiedzialnoscia spólka jawna. Electronic Medicines Compendium (EMC). [Revised in March 2022] [Accessed on 28th October 2022] https://www.medicines.org.uk/emc/files/pil.782.pdf
4. Sanofi-aventis U.S. LLC. Enoxaparin. [Revised in April 2022] [Accessed on 28th October 2022] https://products.sanofi.us/lovenox/lovenox.pdf
5. Bharat Serums and Vaccines Limited. Lonopin. Enoxaparin Injection. IP. 20mg/40mg/60mg. [Revised in November 2018]. [Accessed on 28th October 2022] https://bsvgroup.com/assets/pdf/products/Re-LONOPIN-20-40-60mg-Common-Pack-Insert-for-Domestic-(Zen-Pharma-LL)-03-12-18-App.pdf
6. Central Drugs Standard Control Organization. Enoxaparin Sodium Injection (Addl. Indication). [Revised in August 2009]. Sodium Enoxaparin (LMWH) [Revised in March 1992]. Enoxaparin Sodium Inj. [Revised in March 2000]. [Accessed on 28th October 2022] https://cdscoonline.gov.in/CDSCO/Drugs
Written By Srilekha. R, B.Pharm
Last updated on 14 Mar 2023 | 06:02 PM(IST)
Enoxaparin INJECTION : Therapeutic Uses, Warning and Precautions, Interactions, Directions for Use, Side Effects and Storage
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.